Filter
205
Text search:
drugs
and
related
substances
act
Featured
Recommendations
26
New Publications
48
Language
Document type
No document type
119
Studies & Reports
26
Guidelines
26
Manuals
9
Training Material
9
Strategic & Response Plan
9
Situation Updates
2
Resource Platforms
2
Fact sheets
2
Infographics
1
Countries / Regions
South Africa
15
India
11
Kenya
9
Western and Central Europe
9
Nigeria
7
Ghana
7
Global
7
Ethiopia
6
Sierra Leone
5
Nepal
5
Liberia
4
Zimbabwe
4
Tanzania
4
Uganda
3
Afghanistan
3
Zambia
3
Syria
3
Botswana
3
Philippines
2
Rwanda
2
Indonesia
2
South–East Asia Region
2
Eastern Europe
2
Guinea
1
USA
1
Pakistan
1
Iraq
1
Germany
1
Cambodia
1
Thailand
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Namibia
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Asia
1
Bhutan
1
Southern Africa
1
Estonia
1
Moldova
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
15
Public Health
13
Women & Child Health
13
Capacity Building
6
Key Resources
5
Pharmacy & Technologies
3
Toolboxes
HIV
25
Mental Health
23
AMR
17
Pharmacy
16
TB
10
Planetary Health
5
Caregiver
4
NCDs
4
Ebola & Marburg
3
Conflict
3
Rapid Response
3
Refugee
3
Specific Hazards
3
COVID-19
3
Natural Hazards
1
Global Health Education
1
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur,
...
Making the Case for Alcohol as a Public Health Threat in the Region. The purpose of this document is to explain the need for making alcohol a top public health priority in the region and the need for national
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbate
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis
...
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated
...
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). The focus of this module is on building the knowledge
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability o
...
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded
...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
An action research conducted in Bang Shau village Northern Shan State, Myanmar
PMPB/INS-GUIDE/02
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to imple
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
